ATP Barcelona 2017

Biological optimisations Limitations

 Knowledge about biological effects and clinical data is scarce and incomplete

 The models are insufficient and the parameters are uncertain

 Models are not self-limiting: dose distributions can be generated beyond the model’s range of validity